REMEGEN CO. LTD YC 1 (REG) — Capital Reinvestment Ratio

Latest as of December 2025: 3.82x

REMEGEN CO. LTD YC 1 (REG) has a Capital Reinvestment Ratio of 3.82x as of December 2025, meaning it reinvests 4% of its operating cash flow (€52.34 Million) in capital expenditures (€200.01 Million). Check REMEGEN CO. LTD YC 1 tangible book value ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

3.82x
Capex / Operating Cash Flow

Operating Cash Flow

€52.34 Million
EUR

Capital Expenditures

€200.01 Million
EUR

Data as of

Dec 2025
Most recent filing

REMEGEN CO. LTD YC 1 Capital Reinvestment Ratio (2021–2025)

This chart tracks REMEGEN CO. LTD YC 1's Capital Reinvestment Ratio across 2 annual periods. For the full cash flow conversion analysis, see REMEGEN CO. LTD YC 1 operating cash flow efficiency.

Annual Capital Reinvestment Ratio for REMEGEN CO. LTD YC 1 (2021–2025)

Year-by-year Capital Reinvestment Ratio for REMEGEN CO. LTD YC 1 from 2021 to 2025. See REG cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (EUR) Capital Expenditures YoY Change
2025 3.82x €52.34 Million €200.01 Million ▲ +63.2%
2021 2.34x €263.63 Million €617.34 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow